Skip to main content

Pliant Therapeutics, Inc.

PLRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001746473

No open-market purchases or sales by Pliant Therapeutics, Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $54.8M in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding Pliant Therapeutics, Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of PLRX: Q4 2022 compared with Q1 2023
MeasureQ4 2022Of which not filed for Q1 2023Q1 2023Change
Holders1251143+19
Shares44.7M10.8K56.2M+11.5M (+25.8%)
Value$864.1M$208.6K$1.50B+$631.5M (+73.1%)

1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (42)

Institutions that held Pliant Therapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to PLRX in Q1 2023
InstitutionSharesValue% of portfolio
Ra Capital Management, L.P.1,762,000$46.9M1.06%
Rock Springs Capital Management LP491,221$13.1M0.31%
Victory Capital Management Inc397,897$10.6M0.01%
Artal Group S.A.255,085$6.79M0.40%
Candriam Luxembourg S.C.A.240,000$5.88M0.04%
HRT Financial LP165,512$4.40M0.05%
Atika Capital Management LLC109,190$2.90M0.45%
Twinbeech Capital LP81,422$2.17M0.04%
Maven Securities LTD75,000$2.00M0.31%
EAM Investors, LLC69,292$1.84M0.36%
Connor, Clark & Lunn Investment Management Ltd.43,479$1.16M0.01%
Verition Fund Management LLC40,802$1.09M0.02%
Pentwater Capital Management LP40,000$1.06M0.02%
Voya Investment Management LLC38,145$1.01M0.00%
Algert Global LLC30,650$815.3K0.04%
Skandinaviska Enskilda Banken AB (publ)30,490$811.0K0.01%
DekaBank Deutsche Girozentrale30,000$782.0K0.00%
Janus Henderson Group PLC17,517$465.9K0.00%
Diametric Capital, LP16,463$437.9K0.21%
Engineers Gate Manager LP14,789$393.4K0.02%
Teacher Retirement System of Texas13,190$351.0K0.00%
Y-Intercept (Hong Kong) Ltd11,829$314.7K0.04%
SEI Investments Co11,354$302.0K0.00%
UBS Oconnor LLC10,500$279.3K0.01%
Group One Trading, L.P.10,372$275.9K0.01%
Point72 Asset Management, L.P.9,697$257.9K0.00%
First Republic Investment Management, Inc.9,384$249.6K0.00%
Virtu Financial LLC9,150$243.0K0.03%
Schonfeld Strategic Advisors LLC8,582$228.3K0.00%
LPL Financial LLC8,080$214.9K0.00%
Walleye Trading LLC8,064$214.5K0.01%
Point72 Middle East FZE7,783$207.0K0.01%
Oppenheimer & Co Inc7,667$203.9K0.00%
Simplex Trading, LLC1,776$47.0K0.00%
Walleye Capital LLC1,213$32.3K0.00%
The PNC Financial Services Group, Inc.191$5.08K0.00%
Truvestments Capital LLC184$4.89K0.00%
Private Trust Co NA106$2.82K0.00%
TCI Wealth Advisors, Inc.51$1.36K0.00%
Bogart Wealth, LLC29$7710.00%
International Assets Investment Management, LLC9$2390.00%
Proequities, Inc.7$1860.00%

Sold out (23)

Institutions that held Pliant Therapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.

Not filed for Q1 2023 yet (1)

Institutions that held Pliant Therapeutics, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PLRX in Q4 2022 that haven't filed for Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
Personal Capital Advisors Corp10,790$208.6K